Fisher Asset Management
TYRA icon

Fisher Asset Management’s Tyra Biosciences TYRA Stock Holding History

Fisher Asset Management’s Portfolio TYRA Stock Details TYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.92M Buy
60,230
+31,430
+109% +$1.04M ﹤0.01% 596
2026
Q1 		$1.1M Hold
28,800
– – ﹤0.01% 674
2025
Q4 		$757K Buy
+28,800
New +$529K ﹤0.01% 719

Other funds holding TYRA

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
APMC
Alta Partners Management Company Jackson, Wyoming $127M AUM 230.85% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return

Fisher Asset Management's TYRA Position: Q2 2026 in Review

Fisher Asset Management increased its Tyra Biosciences (TYRA) stake by 109% in Q2 2026, buying an estimated $1.04M and bringing the position to 60,230 shares worth $1.92M. The position accounts for ﹤0.01% of the portfolio, ranked #596.

Fisher Asset Management first reported a position in TYRA in Q4 2025 and has held it in 3 quarters since. 168 funds tracked by Wall St. Rank hold TYRA as of Q2 2026.

  • Fisher Asset Management held 60,230 shares of Tyra Biosciences worth $1.92M as of Q2 2026.
  • Fisher Asset Management bought 31,430 Tyra Biosciences shares in Q2 2026, an estimated $1.04M.
  • Tyra Biosciences made up ﹤0.01% of Fisher Asset Management's portfolio in Q2 2026, its #596 holding.
  • Fisher Asset Management first reported a position in Tyra Biosciences in Q4 2025 and has held it in 3 quarters since.
  • 168 funds tracked by Wall St. Rank held Tyra Biosciences as of Q2 2026.

Based on Fisher Asset Management's 13F filing for Q2 2026, filed 4 Aug 2026.